SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-014370
Filing Date
2024-05-23
Accepted
2024-05-23 18:02:45
Documents
1
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 form4-05232024_100533.html 4  
1 form4-05232024_100533.xml 4 4062
  Complete submission text file 0001415889-24-014370.txt   5526
Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES ST. NEW YORK NY 10013
Business Address
Pruzanski Mark (Reporting) CIK: 0001559569 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38692 | Film No.: 24980070

Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Issuer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)